cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.

David Louis (1) , Caterina Giannini (2) , David Capper (3) , Werner Paulus (4) , Dominique Figarella-Branger (5) , M Beatriz Lopes (6) , Tracy Batchelor (1) , J Gregory Cairncross (7) , Martin van den Bent (8) , Wolfgang N Wick (9, 10) , Pieter Wesseling (11, 12)

1 Massachusetts General Hospital [Boston]
2 Department of Computer Science [Rochester]
3 BIH - Berlin Institute of Health
4 Institute of Neuropathology University Hospital Münster
5 INP - Institut de neurophysiopathologie
6 Department of Pathology [Charlottesville, US]
7 charbonneau cancer institute universite of calgary
8 the brain tumor center Rotterdam
9 Clinical Cooperation Unit Neuropathology
10 neurology clinical and national center for tumor diseases Heidelberg germany
11 Department of Pathology
12 Princess Máxima Center for Pediatric Oncology

Domains: Life Sciences [q-bio]

David Louis, Caterina Giannini, David Capper, Werner Paulus, Dominique Figarella-Branger, et al.. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.. Acta Neuropathologica, 2018, pp.639-642. ⟨10.1007/s00401-018-1826-y⟩. ⟨hal-01771458⟩